In this Issue
CHIEF MEDICAL EDITOR’S PAGE
By Sanjeev Vaishnavi, MD, PhD
ABOUT THE COVER ARTIST
Is the cause of MS within us?
By Daniel Kantor, MD, FAAN, FANA
Erenumab approval heralds a new era in headache medicine.
By Peter McAllister, MD
COVER FOCUS: ALZHEIMER’S DISEASE
Anticipating a novel clinical practice.
By Kristin Harkins, MPH; and Jason Karlawish, MD
Clinicians can address the challenges of stigma in routine clinical practice.
By Shana D. Stites, PsyD, MS, MA; and Jason Karlawish, MD
We can find art in Alzheimer’s disease.
By Daniel C. Potts, MD, FAAN; Neelum T. Aggarwal, MD; and Angel C. Duncan, MA, MFT-ATR
The central theme is supportive care aimed at improving quality of life.
By Riddhi Patira, MD; and Sanjeev Vaishnavi, MD, PhD
Sleep and circadian rhythm disturbances are symptoms of Alzheimer’s disease that may also contribute to disease pathogenesis.
By Erik S. Musiek, MD, PhD
An Interview with Rachelle S. Doody, MD, PhD
The inherent risk of medicine mandates both risk management and asset protection.
By David B. Mandell, JD, MBA; and Jason M. O’Dell, MS, CWM
Awareness of pathognomonic findings may prevent unnecessary tests and treatments.
By Arayamparambil C. Anilkumar, MD
Providers should have a high index of suspicion for seizure disorders in patients with Alzheimer’s disease.